AR012989A1 - Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. - Google Patents
Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa.Info
- Publication number
- AR012989A1 AR012989A1 ARP980102859A ARP980102859A AR012989A1 AR 012989 A1 AR012989 A1 AR 012989A1 AR P980102859 A ARP980102859 A AR P980102859A AR P980102859 A ARP980102859 A AR P980102859A AR 012989 A1 AR012989 A1 AR 012989A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel sulfonamide
- farnesil
- protein transferase
- sulfonamide inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87705097A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012989A1 true AR012989A1 (es) | 2000-11-22 |
Family
ID=25369146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102859A AR012989A1 (es) | 1997-06-17 | 1998-06-16 | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0989980A1 (xx) |
| JP (1) | JP2002507192A (xx) |
| KR (1) | KR20010013826A (xx) |
| CN (1) | CN1267290A (xx) |
| AR (1) | AR012989A1 (xx) |
| AU (1) | AU8253698A (xx) |
| CA (1) | CA2293358C (xx) |
| CO (1) | CO4940475A1 (xx) |
| HU (1) | HUP0004627A2 (xx) |
| IL (1) | IL133393A0 (xx) |
| NZ (1) | NZ501619A (xx) |
| PE (1) | PE86199A1 (xx) |
| WO (1) | WO1998057949A1 (xx) |
| ZA (1) | ZA985218B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689789B2 (en) | 1997-06-17 | 2004-02-10 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| AU3514302A (en) * | 2000-11-29 | 2002-06-11 | Schering Corp | 0ovel farnesyl protein transferase inhibitors |
| WO2006055187A1 (en) | 2004-10-29 | 2006-05-26 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| KR101464767B1 (ko) | 2005-10-25 | 2014-11-24 | 칼립시스, 인코포레이티드 | Ｐｐａｒ의 조절자의 염 및 대사질환을 치료하는 방법 |
| WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| KR20150119390A (ko) * | 2013-02-19 | 2015-10-23 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 항암제로서의 삼환식 헤테로사이클 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69429440T2 (de) * | 1993-10-15 | 2002-08-08 | Schering Corp | Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
-
1998
- 1998-06-15 JP JP54752198A patent/JP2002507192A/ja active Pending
- 1998-06-15 CN CN98808186A patent/CN1267290A/zh active Pending
- 1998-06-15 WO PCT/US1998/011508 patent/WO1998057949A1/en not_active Application Discontinuation
- 1998-06-15 ZA ZA985218A patent/ZA985218B/xx unknown
- 1998-06-15 AU AU82536/98A patent/AU8253698A/en not_active Abandoned
- 1998-06-15 PE PE1998000508A patent/PE86199A1/es not_active Application Discontinuation
- 1998-06-15 NZ NZ501619A patent/NZ501619A/en unknown
- 1998-06-15 IL IL13339398A patent/IL133393A0/xx unknown
- 1998-06-15 KR KR1019997011846A patent/KR20010013826A/ko not_active Application Discontinuation
- 1998-06-15 CA CA002293358A patent/CA2293358C/en not_active Expired - Fee Related
- 1998-06-15 HU HU0004627A patent/HUP0004627A2/hu unknown
- 1998-06-15 EP EP98932718A patent/EP0989980A1/en not_active Withdrawn
- 1998-06-16 CO CO98034142A patent/CO4940475A1/es unknown
- 1998-06-16 AR ARP980102859A patent/AR012989A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010013826A (ko) | 2001-02-26 |
| CA2293358C (en) | 2008-08-05 |
| WO1998057949A1 (en) | 1998-12-23 |
| CN1267290A (zh) | 2000-09-20 |
| PE86199A1 (es) | 1999-09-24 |
| AU8253698A (en) | 1999-01-04 |
| IL133393A0 (en) | 2001-04-30 |
| JP2002507192A (ja) | 2002-03-05 |
| HUP0004627A2 (hu) | 2001-10-28 |
| CA2293358A1 (en) | 1998-12-23 |
| NZ501619A (en) | 2002-02-01 |
| EP0989980A1 (en) | 2000-04-05 |
| CO4940475A1 (es) | 2000-07-24 |
| ZA985218B (en) | 1998-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tanaka et al. | Hydrophobic regions function in calmodulin-enzyme (s) interactions. | |
| BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
| AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
| MX9206008A (es) | Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida. | |
| TR199800825T2 (xx) | Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri. | |
| BR9814340A (pt) | Derivados de indol como inibidores de fator xa | |
| RU94015838A (ru) | Производные бензофуранил- или бензотиофенилалкан-карбоновой кислоты, смесь их изомеров или отдельные изомеры и их соли | |
| BR9809342A (pt) | Composto, composição farmacêutica, e, uso do composto | |
| FI942423A (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
| BR9713404A (pt) | ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos. | |
| BR9713178A (pt) | Inbidores espirocìclicos da metaloprotease. | |
| Malemud et al. | Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan | |
| BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
| AR012989A1 (es) | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. | |
| EA200000240A1 (ru) | Соединения, препятствующие эффекту раннего превращения лекарственных средств | |
| AR009809A1 (es) | Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos | |
| ES2150461T3 (es) | Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes. | |
| Keraly et al. | Inhibition by ticlopidine of PAF-acether-induced in vitro aggregation of rabbit and human platelets | |
| BR0308601A (pt) | inibidores de carboxipeptidase b de plasma | |
| BR9816072A (pt) | Composição clareadora da pele contendo um composto de ácido ascórbico | |
| ATE299140T1 (de) | Farnesyl-protein transferase inhibitoren | |
| NO20003880L (no) | Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser | |
| ES2054904T3 (es) | Procedimiento para la preparacion de peptidos con actividad inhibidora de sistemas enzimaticos. | |
| ECSP982530A (es) | Novedosos inhibidores de sulfonamida de la farnesil - protein transferasa | |
| ES2164454T3 (es) | Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |